Invention Grant
- Patent Title: Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
-
Application No.: US16038925Application Date: 2018-07-18
-
Publication No.: US11214621B2Publication Date: 2022-01-04
- Inventor: Leda Mannent , Gianluca Pirozzi , Brian Swanson , Allen Radin , Namita A. Gandhi , Robert Evans , Jennifer Hamilton
- Applicant: Sanofi Biotechnology , Regeneran Pharmaceuticals, Inc.
- Applicant Address: FR Paris; US NY Tarrytown
- Assignee: Sanofi Biotechnology,Regeneran Pharmaceuticals, Inc.
- Current Assignee: Sanofi Biotechnology,Regeneran Pharmaceuticals, Inc.
- Current Assignee Address: FR Paris; US NY Tarrytown
- Agency: Lathrop GPM LLP
- Agent James H. Velema; Judith L. Stone-Hulslander
- Priority: EP15306632 20151014
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K31/58 ; A61K31/573 ; A61K9/00 ; A61B5/00 ; A61K39/00
Abstract:
The present invention provides methods for decreasing a nasal polyp score in a subject. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody or antigen binding fragment thereof.
Public/Granted literature
- US20190040147A1 METHODS FOR TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST Public/Granted day:2019-02-07
Information query
